Antimicrobial susceptibility testing for Gram positive cocci towards vancomycin using scanning electron microscopy.
Enterococcus
Gram-positive cocci
Microbiology
Rapid AST
Scanning electron microscopy
Staphylococcus
Vancomycin
Journal
Current research in microbial sciences
ISSN: 2666-5174
Titre abrégé: Curr Res Microb Sci
Pays: Netherlands
ID NLM: 101773003
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
2
8
2022
Statut:
epublish
Résumé
The rapid detection of resistant bacteria has become a challenge for microbiologists worldwide. Numerous pathogens that cause nosocomial infections are still being treated empirically and have developed resistance mechanisms against key antibiotics. Thus, one of the challenges for researchers has been to develop rapid antimicrobial susceptibility testing (AST) to detect resistant isolates, ensuring better antibiotic stewardship. In this study, we established a proof-of-concept for a new strategy of phenotypic AST on Gram-positive cocci towards vancomycin using scanning electron microscopy (SEM). Our study evaluated the profiling of
Identifiants
pubmed: 35909629
doi: 10.1016/j.crmicr.2022.100154
pii: S2666-5174(22)00051-7
pmc: PMC9325908
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100154Informations de copyright
© 2022 The Author(s). Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Authors would like to declare that D.R. was a consultant in microbiology for the Hitachi High-Tech Corporation from March 2018 until March 2021. Y.O. is employed by the company Hitachi High-Tech Corporation. AH is employed by the company Hitachi, Ltd. Personal fees of G.H., S.B., A.F. and J.B. are paid through a collaborative contract from the company Hitachi High-Tech Corporation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Rev Microbiol. 2019 Jan;17(1):51-62
pubmed: 30333569
Clin Microbiol Rev. 2001 Oct;14(4):836-71, table of contents
pubmed: 11585788
APMIS. 2004 Nov-Dec;112(11-12):815-37
pubmed: 15638839
Antibiotics (Basel). 2021 Feb 20;10(2):
pubmed: 33672677
Nat Rev Microbiol. 2020 May;18(5):299-311
pubmed: 32055026
Clin Microbiol Infect. 2009 Mar;15(3):209-11
pubmed: 19335367
J Clin Microbiol. 2018 Mar 26;56(4):
pubmed: 29436417
Clin Chem. 2021 Dec 30;68(1):91-98
pubmed: 34969098
J Clin Microbiol. 1991 Mar;29(3):533-8
pubmed: 2037671
Antimicrob Agents Chemother. 1997 Jun;41(6):1410-1
pubmed: 9174214
Mol Microbiol. 2003 Nov;50(3):871-81
pubmed: 14617148
Front Microbiol. 2021 Jun 16;12:658322
pubmed: 34220746
J Clin Microbiol. 2021 Apr 20;59(5):
pubmed: 33568464
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i40-i43
pubmed: 30690541
J Clin Microbiol. 2018 Mar 26;56(4):
pubmed: 29386262
Future Microbiol. 2019 Oct;14:1331-1341
pubmed: 31526186
Clin Infect Dis. 2003 Jun 1;36(11):1418-23
pubmed: 12766837
Clin Microbiol Infect. 2016 Nov;22(11):946.e9-946.e15
pubmed: 27475737
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
Antimicrob Agents Chemother. 2009 Feb;53(2):800-4
pubmed: 19029329
Microorganisms. 2021 May 28;9(6):
pubmed: 34071713
Antimicrob Resist Infect Control. 2019 Feb 12;8:35
pubmed: 30805182
Oman Med J. 2019 May;34(3):184-193
pubmed: 31110624
Infect Drug Resist. 2018 Nov 28;11:2497-2509
pubmed: 30555249
J Infect. 2014 Sep;69(3):216-25
pubmed: 24841135
Antimicrob Agents Chemother. 2007 Oct;51(10):3627-33
pubmed: 17646417
J Lab Physicians. 2018 Jul-Sep;10(3):260-264
pubmed: 30078959
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5787-E5795
pubmed: 28652348
Biotechnol J. 2019 Jan;14(1):e1700750
pubmed: 30024110
Diagnostics (Basel). 2019 May 03;9(2):
pubmed: 31058811
J Appl Lab Med. 2019 Jan;3(4):686-697
pubmed: 31639736
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):181-5
pubmed: 16505987